Cargando…

A Systematic Review of miRNA and cfDNA as Potential Biomarkers for Liquid Biopsy in Myocarditis and Inflammatory Dilated Cardiomyopathy

Myocarditis and inflammatory dilated cardiomyopathy are cardiac diseases leading to heart failure. Liquid biopsy is a concept of replacing traditional biopsy with specialized blood tests. The study aim was to summarize and assess the usefulness of microRNAs and circulating free DNA as biomarkers of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewandowski, Piotr, Goławski, Marcin, Baron, Maciej, Reichman-Warmusz, Edyta, Wojnicz, Romuald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599237/ https://www.ncbi.nlm.nih.gov/pubmed/36291684 http://dx.doi.org/10.3390/biom12101476

Ejemplares similares

The rationale for using low-molecular weight heparin in the therapy of symptomatic COVID-19 patients
por: Reichman-Warmusz, Edyta, et al.
Publicado: (2022)

The relationship between late gadolinium enhancement imaging and myocardial biopsy in the evaluation of chronic heart failure patients with suspected myocarditis
por: Nowak, Jolanta, et al.
Publicado: (2014)

Circulating cf-miRNA as a more appropriate surrogate liquid biopsy marker than cfDNA for ovarian cancer
por: Gahlawat, Aoife Ward, et al.
Publicado: (2023)

Aspiration thrombectomy and histopathologic examination of thrombus for early identification of embolic myocardial infarction
por: Wybraniec, Maciej T., et al.
Publicado: (2019)

Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing
por: Medina Diaz, Inga, et al.
Publicado: (2016)

The Correlation of PPARα Activity and Cardiomyocyte Metabolism and Structure in Idiopathic Dilated Cardiomyopathy during Heart Failure Progression
por: Czarnowska, E., et al.
Publicado: (2016)

Nosological and Theranostic Approach to Vascular Malformation through cfDNA NGS Liquid Biopsy
por: Serio, Viola Bianca, et al.
Publicado: (2022)

Liquid biopsy using cfDNA to predict radiation therapy response in solid tumors
por: Cho, Won Kyung, et al.
Publicado: (2023)

Impact of cfDNA Reference Materials on Clinical Performance of Liquid Biopsy NGS Assays
por: Hallermayr, Ariane, et al.
Publicado: (2023)

Utility of cfDNA Fragmentation Patterns in Designing the Liquid Biopsy Profiling Panels to Improve Their Sensitivity
por: Ivanov, Maxim, et al.
Publicado: (2019)

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer
por: Casas-Arozamena, Carlos, et al.
Publicado: (2020)

von Willebrand factor in iris vasculature of glaucoma patients
por: Rokicki, Wojciech, et al.
Publicado: (2014)

The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract
por: Brzozowa, Marlena, et al.
Publicado: (2015)

Inducible and Endothelial Nitric Synthetase Expression and Nitrotyrosine Accumulation in Iris Vasculature of Patients with Primary Open-Angle Glaucoma: A Pilot Study
por: Rokicki, Wojciech, et al.
Publicado: (2015)

Biopsy-proven autoimmune myocarditis in HIV-associated dilated cardiomyopathy
por: Frustaci, Andrea, et al.
Publicado: (2014)

Microfluidic Technologies for cfDNA Isolation and Analysis
por: Xu, Zheyun, et al.
Publicado: (2019)

Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC?
por: Li, Yi-Ze, et al.
Publicado: (2023)

Myocarditis and idiopathic dilated cardiomyopathy
por: Brown, Charles A., et al.
Publicado: (1995)

Early detection of colorectal cancer somatic mutations using cfDNA liquid biopsies in a murine carcinogenesis model
por: Martínez-Gregorio, Héctor, et al.
Publicado: (2022)

Combinatorial Power of cfDNA, CTCs and EVs in Oncology
por: Keup, Corinna, et al.
Publicado: (2022)

cfDNA Sequencing: Technological Approaches and Bioinformatic Issues
por: Bohers, Elodie, et al.
Publicado: (2021)

Plasma cfDNA predictors of established bacteraemic infection
por: Urosevic, Nadezda, et al.
Publicado: (2022)

Plasma cfDNA for the Diagnosis and Prognosis of Colorectal Cancer
por: Wu, Zhiwei, et al.
Publicado: (2022)

Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort
por: Fairclough, Stephen R., et al.
Publicado: (2019)

In silico error correction improves cfDNA mutation calling
por: Kim, Chang Sik, et al.
Publicado: (2019)

Comparison of the source and prognostic utility of cfDNA in trauma and sepsis
por: Jackson Chornenki, Nicholas L., et al.
Publicado: (2019)

Novel technologies in cfDNA analysis and potential utility in clinic
por: Li, Jie, et al.
Publicado: (2021)

cfDNA in pancreatic neuroendocrine carcinoma management with Cushing’s syndrome
por: Gerard, Laura, et al.
Publicado: (2021)

Drug Therapy in Dilated Cardiomyopathy and Myocarditis
por: Barron, Hal
Publicado: (1989)

Endomyocardial Biopsy in Pediatric Myocarditis and Dilated Cardiomyopathy: A Tool in Search for a Role
por: Pilati, Mara, et al.
Publicado: (2022)

The influence of hypoxic physical activity on cfDNA as a new marker of vascular inflammation
por: Pokrywka, Andrzej, et al.
Publicado: (2015)

Identification of Immunoglobulin Gene Rearrangement Biomarkers in Multiple Myeloma through cfDNA-Based Liquid Biopsy Using tchDNA-Seq
por: Buenache, Natalia, et al.
Publicado: (2023)

Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA
por: Togneri, Fiona S, et al.
Publicado: (2016)

cfDNA screening and diagnosis of monogenic disorders – where are we heading?
por: Chiu, Eunice Ka Long, et al.
Publicado: (2018)

Detection of LINE-1 hypomethylation in cfDNA of Esophageal Adenocarcinoma Patients
por: Boldrin, Elisa, et al.
Publicado: (2020)

Impact of mosaicism ratio on positive predictive value of cfDNA screening
por: Rafalko, Jill M., et al.
Publicado: (2020)

cfDNA Changes in Maximal Exercises as a Sport Adaptation Predictor
por: Humińska-Lisowska, Kinga, et al.
Publicado: (2021)

Deep cfDNA fragment end profiling enables cancer detection
por: Zhitnyuk, Yulia V., et al.
Publicado: (2022)

Dynamics of Specific cfDNA Fragments in the Plasma of Full Marathon Participants
por: Sugasawa, Takehito, et al.
Publicado: (2021)

The utility of cfDNA in TGCT patient management: a systematic review
por: Krasic, Jure, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5mjo8u9lemahj2onrrn7ogh1t1